The New York State Department of Health, AIDS Institute has awarded the Institute for Advanced Medicine (IAM) at the Mount Sinai Health System, a five-year, $5 million clinical education and training grant to help health care providers in New York State improve the outcomes of patients with HIV, hepatitis C (HCV), and sexually transmitted diseases (STDs).
The Mount Sinai Hospital has been ranked No. 16 out of nearly 5,000 hospitals nationwide in the U.S. News & World Report 2014–15 “Best Hospitals” guidebook. Additionally, New York Eye and Ear Infirmary of Mount Sinai achieved a No. 10 national ranking for Ophthalmology, while Mount Sinai Beth Israel and Mount Sinai St. Luke’s/Mount Sinai Roosevelt attained “high-performing” designations in a total of 11 specialties.
Further, according to U.S. News & World Report, The Mount Sinai Hospital is one of only 17 hospitals to receive “very high scores” in at least six clinical specialties, earning it Honor Roll status.
The future of medicine, maintaining an edge in biomedical innovation, and the cost of health care in America were among the topics explored by Mount Sinai Health System leaders during the 2014 Aspen Ideas Festival, a yearly conclave that attracts several thousand policy makers, innovators, entrepreneurs, and executives who participate in thought-provoking discussions on health care and other major issues that impact America.
A recent New York Times article started with this vignette:
“Kim Little had not thought much about the tiny white spot on the side of her cheek until a physician’s assistant at her dermatologist’s office warned that it might be cancerous. He took a biopsy, returning 15 minutes later to confirm the diagnosis and schedule her for an outpatient procedure at the Arkansas Skin Cancer Center in Little Rock, 30 miles away.
Recently an article in Newsday addressed the question: “Do you know if your primary care physician will manage your care if you are admitted to the hospital?”
“Reflecting today’s changing medical practices, some primary care doctors don’t set foot inside their patients’ hospital rooms at all — leaving their care to physicians called hospitalists.
A recent USA Today article noted “The Medicare metric for timely heart attack treatment is … “door-to-balloon” time — the time between when a heart attack patient arrives in the ER and when the balloon angiography begins — researchers found that the percentage of heart attack patients who die while in the hospital, about 5%, hasn’t changed.”
“Irreversible damage from a heart attack can begin in 30 minutes. Most tissue death occurs in the first two to three hours…” “A new study suggests that speeding up hospital care isn’t enough to save lives … A better predictor of survival might be ‘symptom to balloon time’…”
CNN reported: “Global health experts on Friday declared the Ebola epidemic ravaging West Africa an international health emergency that requires a coordinated global approach.”
“’Guinea, Liberia and Sierra Leone are battling the Ebola virus, which has also spread to Nigeria. The virus is believed to have infected 1,779 people, killing 961, from the start of the outbreak earlier this year through Wednesday,’ the World Health Organization said.”
You arrive at the hospital at 6AM and while being prepped for the procedure a gowned or capped individual introduces himself or herself to you and says “I will be administering your anesthesia.”
You need to know what kind of anesthesia you will be getting. “In general anesthesia, you are unconscious and have no awareness or other sensations. In regional anesthesia, your anesthesiologist makes an injection near a cluster of nerves to numb the area of your body that requires surgery. You may remain awake, or you may be given a sedative. In local anesthesia, the anesthetic drug is usually injected into the tissue to numb just the specific location of your body requiring minor surgery.”
A recent Modern Healthcare article reported that: “ More than half of adults between ages 40 and 75 who need help managing cholesterol would be eligible for statin therapy for the prevention of heart disease on the basis of the newest American College of Cardiology and American Heart Association guidelines…The new guidelines have the potential to increase the net number of new statin prescriptions by 12.8 million.”
“With more than 115 million U.S. adults estimated to be between the ages of 40 and 75, the analysis suggests the total number of potential statin users could expand to 56 million, and the majority would be above age 60.”